Central & Peripheral blood flow regulation in individuals with Down syndrome

中央

基本信息

  • 批准号:
    9371097
  • 负责人:
  • 金额:
    $ 10.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-05 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Work capacity is an important predictor of declining health or physical function, and of mortality, and is commonly measured as peak oxygen consumption. Peak oxygen consumption is very low in individuals with Down syndrome, the most prevalent genetic cause of intellectual disability. Previous research suggests individuals with Down syndrome may experience a double disadvantage when they are exercising: they may not be able to increase cardiac output sufficiently and they may not be able to allocate adequate blood flow to the working muscles. The overall aim of this research proposal is therefore to determine the impact of limitations in central and peripheral regulation of blood flow on work capacity in individuals with DS. We aim to examine both acute and chronic exercise responses to better understand the underlying mechanisms and the potential to improve health by using this knowledge in interventions. The candidate, Dr. Thessa Hilgenkamp, has a strong background in epidemiological research on health in individuals with intellectual disabilities including Down syndrome. Her research focuses on the benefits of physical activity and exercise in this population, and she has shown great potential to become a successful independent researcher in this field. Recently she has developed expertise in measuring autonomic regulation during exercise with Dr. Bo Fernhall in the Integrative Physiology Laboratory of the University of Illinois at Chicago. Her long-term goal is to improve the health of individuals with Down syndrome across the life span, by fully understanding autonomic dysfunction and cardiovascular regulation of the response to exercise and implementing this knowledge in physical activity and exercise interventions. Her short-term career goals are first to become a skilled, knowledgeable expert on cardiovascular exercise physiology and autonomic function in individuals with Down syndrome, and second to become a high-potential researcher in this specific field, both from the perspective of academia and from the perspective of clinical practice and the Down syndrome support networks in the community. This Career Development Award will allow her to receive additional training in technical knowledge and skills that will be in line with and complementary to the research proposal, to conduct research projects in collaboration with clinical practice and the Down syndrome support networks in the community, and to develop transferable skills necessary to become a successful independent researcher, such as grant writing, lab management and mentoring. Her mentor is Dr. Bo Fernhall, a world-renowned expert on cardiovascular exercise physiology and Down syndrome, and she will also be supported by Dr. Tracy Baynard and Dr. Philip Clifford of the Department of Kinesiology and Nutrition of the University of Illinois at Chicago. This Department is committed to Dr. Hilgenkamp's academic development and provides her with all the facilities she needs, including the equipment in the Integrative Physiology Laboratory that she needs. She also has the support of parent networks and the Special Olympics Illinois to conduct this research.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thessa Hilgenkamp其他文献

Thessa Hilgenkamp的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thessa Hilgenkamp', 18)}}的其他基金

Predictors of mortality and of healthy survival in a large community-based prospective cohort of aging adults with Down syndrome
大型社区前瞻性唐氏综合症老年人队列中死亡率和健康生存的预测因子
  • 批准号:
    10703503
  • 财政年份:
    2022
  • 资助金额:
    $ 10.16万
  • 项目类别:
Predictors of mortality and of healthy survival in a large community-based prospective cohort of aging adults with Down syndrome
大型社区前瞻性唐氏综合症老年人队列中死亡率和健康生存的预测因子
  • 批准号:
    10515414
  • 财政年份:
    2022
  • 资助金额:
    $ 10.16万
  • 项目类别:
Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
  • 批准号:
    10020792
  • 财政年份:
    2019
  • 资助金额:
    $ 10.16万
  • 项目类别:
Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
  • 批准号:
    10254383
  • 财政年份:
    2019
  • 资助金额:
    $ 10.16万
  • 项目类别:
Central & Peripheral blood flow regulation in individuals with Down syndrome
中央
  • 批准号:
    10018130
  • 财政年份:
    2019
  • 资助金额:
    $ 10.16万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 10.16万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了